NL8501682A - Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten. - Google Patents

Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten. Download PDF

Info

Publication number
NL8501682A
NL8501682A NL8501682A NL8501682A NL8501682A NL 8501682 A NL8501682 A NL 8501682A NL 8501682 A NL8501682 A NL 8501682A NL 8501682 A NL8501682 A NL 8501682A NL 8501682 A NL8501682 A NL 8501682A
Authority
NL
Netherlands
Prior art keywords
protein
tetranectin
plasminogen
blood
kringle
Prior art date
Application number
NL8501682A
Other languages
English (en)
Dutch (nl)
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Priority to NL8501682A priority Critical patent/NL8501682A/nl
Priority to DE8686201005T priority patent/DE3667061D1/de
Priority to EP86201005A priority patent/EP0206400B1/en
Priority to AT86201005T priority patent/ATE48142T1/de
Priority to US06/872,613 priority patent/US4853220A/en
Priority to JP61135864A priority patent/JPH0676438B2/ja
Publication of NL8501682A publication Critical patent/NL8501682A/nl
Priority to US07/384,283 priority patent/US5064942A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL8501682A 1985-06-11 1985-06-11 Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten. NL8501682A (nl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NL8501682A NL8501682A (nl) 1985-06-11 1985-06-11 Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten.
DE8686201005T DE3667061D1 (en) 1985-06-11 1986-06-10 New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
EP86201005A EP0206400B1 (en) 1985-06-11 1986-06-10 New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
AT86201005T ATE48142T1 (de) 1985-06-11 1986-06-10 Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
US06/872,613 US4853220A (en) 1985-06-11 1986-06-10 Protein isolated from blood, process for preparing said protein, aantibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
JP61135864A JPH0676438B2 (ja) 1985-06-11 1986-06-11 血液から単離された蛋白質、該蛋白質の製造方法および該蛋白質を含有する製薬学的組成物
US07/384,283 US5064942A (en) 1985-06-11 1989-07-21 Protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8501682 1985-06-11
NL8501682A NL8501682A (nl) 1985-06-11 1985-06-11 Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten.

Publications (1)

Publication Number Publication Date
NL8501682A true NL8501682A (nl) 1987-01-02

Family

ID=19846125

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501682A NL8501682A (nl) 1985-06-11 1985-06-11 Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten.

Country Status (6)

Country Link
US (2) US4853220A (ja)
EP (1) EP0206400B1 (ja)
JP (1) JPH0676438B2 (ja)
AT (1) ATE48142T1 (ja)
DE (1) DE3667061D1 (ja)
NL (1) NL8501682A (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5759855A (en) * 1988-09-14 1998-06-02 La Jolla Cancer Research Foundation Methods for modifying the binding activity of cell adhesion receptors
US5574134A (en) * 1989-07-11 1996-11-12 University Of Delaware Polypeptide monomers, linearly extended and/or crosslinked forms thereof, and applications thereof
WO1991015765A1 (en) * 1990-03-30 1991-10-17 Swank Roy L Diagnostic test for multiple sclerosis
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
DE19533817C2 (de) * 1995-09-13 1999-12-09 Max Planck Gesellschaft Komplex-gebundene Hemmstoffe aktivierbarer Stoffwechselenzyme als molekulare Marker zur Diagnostik und Therapieüberwachung
PT1012280E (pt) * 1997-06-11 2005-02-28 Borean Pharma As Modulo de trimerizacao
TWI243852B (en) * 1998-06-15 2005-11-21 Pharmacia & Upjohn Ab Angiogenesis related molecules
US6908898B1 (en) 1998-06-15 2005-06-21 Lars Holmgren Angiogenesis related molecules
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US6855263B2 (en) * 2002-07-23 2005-02-15 Nuvue Technologies, Inc. Rapid process for purification and concentration of plasmin
US11124558B2 (en) 2017-06-02 2021-09-21 The Feinstein Institutes For Medical Research Use of tetranectin and peptide agonists to treat inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon

Also Published As

Publication number Publication date
EP0206400B1 (en) 1989-11-23
ATE48142T1 (de) 1989-12-15
US4853220A (en) 1989-08-01
EP0206400A1 (en) 1986-12-30
JPS62181299A (ja) 1987-08-08
DE3667061D1 (en) 1989-12-28
JPH0676438B2 (ja) 1994-09-28
US5064942A (en) 1991-11-12

Similar Documents

Publication Publication Date Title
Guinto et al. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C.
Tsai Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
Clemmensen et al. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin
Dahlbäck Interaction between vitamin K-dependent protein S and the complement protein, C4b-binding protein
Wachtfogel et al. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5).
Stenflo A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization.
US5202253A (en) Monoclonal antibody specific for protein C and antibody purification method
Dela et al. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc‐dependent binding to an anionic surface
Dahlbäck et al. Localization of thrombin cleavage sites in the amino-terminal region of bovine protein S.
Kunapuli et al. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains.
Ingham et al. Further Localization of the Gelatin-binding Determinants within Fibronectin: Active fragments devoid of type ii homologous repeat modules
Berman Structural properties of acetylcholinesterase from eel electric tissue and bovine erythrocyte membranes
KR940002033B1 (ko) 단백질 c에 대해 특이성이 있는 단클론성 항체 및 항체의 분리방법
NL8501682A (nl) Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten.
Bock et al. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
Bennett Isolation of an ankyrin-band 3 oligomer from human erythrocyte membranes
US20040186277A1 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
McGuire et al. Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain.
DePoli et al. Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
Berkowitz et al. Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease
Koppelman et al. Synergistic inhibition of the intrinsic factor X activation by protein S and C4b-binding protein
Kerr [6] The second component of human complement
Habal et al. Kininogens of human plasma
WO1986000910A1 (en) Immunopurification process

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed